## Diagnosis: Lambert-Eaton Myasthenic Syndrome (LEMS) This patient presents with the characteristic features of **Lambert-Eaton myasthenic syndrome (LEMS)**: - **Proximal muscle weakness** (hip flexors, knee extensors) — typical distribution - **Paraneoplastic association** — small-cell lung cancer (SCLC) in 50–60% of LEMS cases - **Decremental response on repetitive nerve stimulation** — key electrophysiological finding - **Normal serum electrolytes** — rules out hypokalemia or hypomagnesemia as causes ## Pathophysiology: Presynaptic Calcium Channel Dysfunction **Key Point:** LEMS is caused by **IgG autoantibodies against presynaptic voltage-gated calcium channels (P/Q-type and N-type)**, which are essential for acetylcholine release. ### Mechanism of Weakness: 1. **Antibody binding** → calcium channel blockade and complement-mediated destruction 2. **Reduced Ca²⁺ influx** → decreased acetylcholine quantal release 3. **Impaired neuromuscular transmission** → muscle weakness ### Why Decremental Response Occurs: With each successive stimulation, the already-depleted acetylcholine pool becomes further exhausted, causing progressive decline in compound muscle action potential (CMAP) amplitude — the hallmark of **presynaptic dysfunction**. **Clinical Pearl:** LEMS differs from myasthenia gravis: - **Facilitation** (not fatigability) occurs with high-frequency stimulation or brief isometric exercise — calcium channels recover partially with repeated depolarization - **Autonomic symptoms** are common (dry mouth, impotence, constipation) due to involvement of autonomic presynaptic terminals - **Proximal weakness** predominates (vs. ocular/bulbar in MG) **High-Yield:** 3-4-diaminopyridine (3,4-DAP) is the first-line treatment — it blocks presynaptic potassium channels, prolonging depolarization and allowing more time for calcium influx and acetylcholine release. **Mnemonic: LEMS vs MG** - **LEMS:** **L**ow ACh release (presynaptic), **E**asily **F**acilitated, **M**alignancy common, **S**mall-cell lung cancer - **MG:** **M**issing receptors (postsynaptic), **F**atigability, **A**uto-immune, **S**eronegative subset
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.